These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34062126)

  • 21. Serological and molecular retrospective analysis of hepatitis E suspected cases from the Eastern Brazilian Amazon 1993-2014.
    Souza AJS; Malheiros AP; Sarmento VP; Resende FS; Alves MM; Nunes HM; Soares MDCP; Sá LRM
    Rev Soc Bras Med Trop; 2019 Apr; 52():e20180465. PubMed ID: 31038622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis E infection in stem cell and solid organ transplantpatients: A cross-sectional study: The importance of HEV RNA screening in peri-transplant period.
    Reekie I; Irish D; Ijaz S; Fox T; Bharucha T; Griffiths P; Thorburn D; Harber M; MacKinnon S; Sekhar M
    J Clin Virol; 2018 Oct; 107():1-5. PubMed ID: 30099145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy.
    Gardinali NR; Guimarães JR; Melgaço JG; Kevorkian YB; Bottino FO; Vieira YR; da Silva AC; Pinto DP; da Fonseca LB; Vilhena LS; Uiechi E; da Silva MC; Moran J; Marchevsky RS; Cruz OG; Otonel RA; Alfieri AA; de Oliveira JM; Gaspar AM; Pinto MA
    PLoS One; 2017; 12(3):e0174070. PubMed ID: 28328941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No evidence of occult hepatitis C or E virus infections in liver-transplant patients with sustained virological response after therapy with direct acting agents.
    Del Bello A; Abravanel F; Alric L; Lavayssiere L; Lhomme S; Bellière J; Izopet J; Kamar N
    Transpl Infect Dis; 2019 Aug; 21(4):e13093. PubMed ID: 30972874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States.
    Koning L; Charlton MR; Pas SD; Heimbach JK; Osterhaus AD; Watt KD; Janssen HL; de Knegt RJ; van der Eijk AA
    BMC Infect Dis; 2015 Sep; 15():371. PubMed ID: 26328802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients--a single-center experience.
    Hoerning A; Hegen B; Wingen AM; Cetiner M; Lainka E; Kathemann S; Fiedler M; Timm J; Wenzel JJ; Hoyer PF; Gerner P
    Pediatr Transplant; 2012 Nov; 16(7):742-7. PubMed ID: 22738211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and clinical correlation of hepatitis E virus antibody in the patients' serum samples from a tertiary care hospital in Thailand during 2015-2018.
    Boonyai A; Thongput A; Sisaeng T; Phumchan P; Horthongkham N; Kantakamalakul W; Chaimayo C
    Virol J; 2021 Jul; 18(1):145. PubMed ID: 34247642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis E Virus Superinfection and Clinical Progression in Hepatitis B Patients.
    Hoan NX; Tong HV; Hecht N; Sy BT; Marcinek P; Meyer CG; Song le H; Toan NL; Kurreck J; Kremsner PG; Bock CT; Velavan TP
    EBioMedicine; 2015 Dec; 2(12):2080-6. PubMed ID: 26844288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis E virus co-infection in HIV-infected patients in Foggia and Naples in southern Italy.
    Scotto G; Grisorio B; Filippini P; Ferrara S; Massa S; Bulla F; Martini S; Filippini A; Tartaglia A; Lo Muzio L; Fazio V
    Infect Dis (Lond); 2015; 47(10):707-13. PubMed ID: 25994453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis E in liver transplant recipients in the Rhône-Alpes region in France.
    Buffaz C; Scholtes C; Dron AG; Chevallier-Queyron P; Ritter J; André P; Ramière C
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):1037-43. PubMed ID: 24445407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Seroprevalence of hepatitis E virus in patients with hepatitis C and / or infected with HIV].
    López-Fabal MF; Gómez-Garcés JL
    Rev Esp Quimioter; 2015 Dec; 28(6):314-6. PubMed ID: 26621176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance Evaluation of Different Commercial Serological Kits for Diagnosis of Acute Hepatitis E Viral Infection.
    Zhang Q; Zong X; Li D; Lin J; Li L
    Pol J Microbiol; 2020 Sep; 69(2):217-222. PubMed ID: 32548990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limited Value of Single Sampling for IgM Antibody Determination as a Diagnostic Approach for Acute Hepatitis E Virus Infection.
    Rivero-Juarez A; Lopez-Lopez P; Pineda JA; Alados JC; Fuentes-López A; Ramirez-Arellano E; Freyre C; Perez AB; Frias M; Rivero A
    Microbiol Spectr; 2021 Sep; 9(1):e0038221. PubMed ID: 34232097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis E Virus Does Not Contribute to Hepatic Decompensation Among Patients With Advanced Chronic Hepatitis C.
    Samala N; Wright EC; Buckler AG; Vargas V; Shetty K; Reddy KR; Lucey MR; Alter HJ; Hoofnagle JH; Ghany MG
    Clin Gastroenterol Hepatol; 2016 Jun; 14(6):896-902. PubMed ID: 26820399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation.
    Unzueta A; Valdez R; Chang YH; Desmarteau YM; Heilman RL; Scott RL; Douglas DD; Rakela J
    Ann Hepatol; 2016; 15(1):33-40. PubMed ID: 26626638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections.
    Abravanel F; Lhomme S; Chapuy-Regaud S; Mansuy JM; Muscari F; Sallusto F; Rostaing L; Kamar N; Izopet J
    J Infect Dis; 2014 Jun; 209(12):1900-6. PubMed ID: 24436450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis E virus infection among patients with altered levels of alanine aminotransferase.
    Conte DD; Luna LKS; Passarini A; Alves VRG; Caldeira DB; Cruz JS; Gouveia VA; Bellei N; Granato CFH
    Braz J Infect Dis; 2021; 25(6):101655. PubMed ID: 34843707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014.
    Lucarelli C; Spada E; Taliani G; Chionne P; Madonna E; Marcantonio C; Pezzotti P; Bruni R; La Rosa G; Pisani G; Dell'Orso L; Ragone K; Tomei C; Ciccaglione AR
    Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised.
    Maylin S; Stephan R; Molina JM; Peraldi MN; Scieux C; Nicand E; Simon F; Delaugerre C
    J Clin Virol; 2012 Apr; 53(4):346-9. PubMed ID: 22293627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.